Fig. 1 · Structure
Documents & Downloads
Seletracetam
SV2A Modulator
Seletracetam is a modulator of the synaptic vesicle protein SV2A, primarily utilized in epilepsy research. As an analog of the antiepileptic drug Levetiracetam, Seletracetam exhibits key biological activity in the modulation of neurotransmitter release, providing insights into seizure mechanisms and potential therapeutic effects. It serves as a valuable tool for investigating synaptic transmission and its implications in neurological disorders.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Modulator |
| CAS Number | 357336-74-4 |
| Applications | SV2A Modulator |
| Formula | C10H14F2N2O2 |
| Molecular Weight | 232.23 |
| Synonyms | Ucb 44212 |
| SMILES | O=C([C@@H](N1C(C[C@H](C1)/C=C(F)\F)=O)CC)N |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.